Winslow Capital Management Cut Position in Abbott Laboratories (ABT) by $7.69 Million; Hudson Valley Investment Advisors Maintains Holding in Eli Lilly & Company (LLY)

Abbott Laboratories (NYSE:ABT) Logo

Winslow Capital Management Llc decreased its stake in Abbott Laboratories (ABT) by 2.91% based on its latest 2019Q2 regulatory filing with the SEC. Winslow Capital Management Llc sold 91,577 shares as the company’s stock rose 10.62% . The institutional investor held 3.06 million shares of the major pharmaceuticals company at the end of 2019Q2, valued at $257.41M, down from 3.15M at the end of the previous reported quarter. Winslow Capital Management Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $149.98 billion market cap company. The stock increased 0.53% or $0.45 during the last trading session, reaching $84.81. About 1.56M shares traded. Abbott Laboratories (NYSE:ABT) has risen 33.65% since December 4, 2018 and is uptrending. It has outperformed by 33.65% the S&P500. Some Historical ABT News: 21/03/2018 – Abbott Hosts Conference Call for First-Quarter Earnings; 18/04/2018 – Abbott Labs 1Q Net $418M; 11/04/2018 – Abbott: Trial Will Assess if Stent Procedures Guided by High-Resolution Imaging Result in Larger Vessel Diameters and Improved Patient Clinical Outcomes; 18/04/2018 – Abbott Labs Sees FY Adj EPS $2.80-Adj EPS $2.90; 09/04/2018 – Commonwealth’s Kimberly Springsteen-Abbott Honored with 2017 WBEC Leadership Award; 18/05/2018 – ABBOTT: THERE IS STILL CONCERN ABOUT EXPLOSIVE DEVICES; 18/04/2018 – ABBOTT LABORATORIES – FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2018 OF APPROXIMATELY $1.57 PER SHARE; 07/03/2018 – Abbott’s Confirm Rx connects an insertable cardiac monitor to a smartphone app; 18/05/2018 – ABBOTT: EXPLOSIVE DEVICES APPARENTLY WERE MADE BY THE SHOOTER; 19/03/2018 – Economic Times: Former Novartis India Head Jawed Zia may Join Abbott

Hudson Valley Investment Advisors Inc increased its stake in Eli Lilly & Company (LLY) by 10.26% based on its latest 2019Q2 regulatory filing with the SEC. Hudson Valley Investment Advisors Inc bought 6,083 shares as the company’s stock declined 7.81% . The institutional investor held 65,371 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $7.24M, up from 59,288 at the end of the previous reported quarter. Hudson Valley Investment Advisors Inc who had been investing in Eli Lilly & Company for a number of months, seems to be bullish on the $113.88 billion market cap company. The stock increased 0.85% or $1 during the last trading session, reaching $118.61. About 1.21 million shares traded. Eli Lilly and Company (NYSE:LLY) has risen 11.15% since December 4, 2018 and is uptrending. It has outperformed by 11.15% the S&P500. Some Historical LLY News: 22/05/2018 – Smithfield® Congratulates Pitmasters Chris Lilly and Tuffy Stone on Wins at 2018 Memphis in May World Championship Barbecue Cooking Contest; 27/04/2018 – Roche’s Perjeta Gets Use Extension Recommendation in Europe; 08/03/2018 – EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research; 23/05/2018 – Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line; 21/05/2018 – Lilly Presenting at UBS Conference Tomorrow; 11/05/2018 – Forteo (teriparatide; Eli Lilly) Drug Overview 2018 – ResearchAndMarkets.com; 03/04/2018 – The European Medicines Agency Accepts Regulatory Submission for LYNPARZA® (olaparib) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer; 03/04/2018 – Merck, AstraZeneca: EMA Accepts Regulatory Submission for Lynparza in BRCA-Mutated HER2-Negative Metastatic Breast Cancer; 06/04/2018 – Lilly set to collect initial Elanco bids – sources [19:23 BST06 Apr 2018] [Proprietary] []; 16/04/2018 – BOEHRINGER,LILLY IN PACT WITH OXFORD ON EMPAGLIFLOZIN STUDY

Investors sentiment increased to 0.71 in Q2 2019. Its up 0.05, from 0.66 in 2019Q1. It increased, as 81 investors sold LLY shares while 459 reduced holdings. 102 funds opened positions while 284 raised stakes. 723.52 million shares or 3.90% less from 752.92 million shares in 2019Q1 were reported. Guardian Advsrs Limited Partnership holds 0.07% or 4,450 shares in its portfolio. The New York-based Klingenstein Fields & Ltd Liability Corporation has invested 0.69% in Eli Lilly and Company (NYSE:LLY). The Japan-based Meiji Yasuda Life Insur Company has invested 0.19% in Eli Lilly and Company (NYSE:LLY). Mackenzie accumulated 84,562 shares or 0.02% of the stock. Martingale Asset Limited Partnership has 458,254 shares for 0.53% of their portfolio. 887 are held by Hudock Cap Group Inc Ltd Liability Corporation. Advisory Service Incorporated holds 4,630 shares. Glynn Mgmt Ltd Limited Liability Company holds 0.26% or 13,490 shares in its portfolio. Dumont And Blake Invest Limited Liability owns 7,550 shares or 0.35% of their US portfolio. Fisher Asset Mgmt Limited Liability Co owns 4.13 million shares. Lipe And Dalton holds 0.01% in Eli Lilly and Company (NYSE:LLY) or 110 shares. The New York-based Cobblestone Cap Advsr Limited Liability Corp Ny has invested 0.03% in Eli Lilly and Company (NYSE:LLY). Millennium Mgmt Ltd Liability Corp owns 8,713 shares or 0% of their US portfolio. Ashford Capital Management owns 0.04% invested in Eli Lilly and Company (NYSE:LLY) for 2,505 shares. Tiverton Asset Ltd Liability holds 0.04% or 9,486 shares.

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Finance.Yahoo.com which released: “Can We See Significant Institutional Ownership On The Eli Lilly and Company (NYSE:LLY) Share Register? – Yahoo Finance” on October 08, 2019, also Prnewswire.com with their article: “ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis – PRNewswire” published on November 12, 2019, Prnewswire.com published: “Eli Lilly and Company to Present Multiple Abstracts for LOXO-305 at ASH 2019 – PRNewswire” on November 06, 2019. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: 247Wallst.com and their article: “Big Pharma Short Sellers Hike Their Bets – 24/7 Wall St.” published on November 27, 2019 as well as Fool.com‘s news article titled: “Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy – Motley Fool” with publication date: November 06, 2019.

Hudson Valley Investment Advisors Inc, which manages about $579.98 million and $431.59 million US Long portfolio, decreased its stake in Exxon Mobil Corporation (NYSE:XOM) by 7,345 shares to 64,820 shares, valued at $4.97 million in 2019Q2, according to the filing. It also reduced its holding in Broadcom Ltd by 1,754 shares in the quarter, leaving it with 17,060 shares, and cut its stake in Amgen Inc Com (NASDAQ:AMGN).

Since June 5, 2019, it had 6 buys, and 10 selling transactions for $115.70 million activity. $20,067 worth of Eli Lilly and Company (NYSE:LLY) was bought by Smiley Joshua L. Ricks David A had bought 4,615 shares worth $500,174 on Friday, October 25. The insider Skovronsky Daniel bought $543,050. Shares for $200,039 were bought by TAI JACKSON P. Another trade for 1,000 shares valued at $108,840 was bought by White Anne E..

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 22. They expect $0.95 earnings per share, up 17.28% or $0.14 from last year’s $0.81 per share. ABT’s profit will be $1.68 billion for 22.32 P/E if the $0.95 EPS becomes a reality. After $0.84 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 13.10% EPS growth.

Investors sentiment increased to 0.89 in Q2 2019. Its up 0.07, from 0.82 in 2019Q1. It improved, as 46 investors sold ABT shares while 589 reduced holdings. 120 funds opened positions while 443 raised stakes. 1.26 billion shares or 0.12% less from 1.26 billion shares in 2019Q1 were reported. Bamco reported 6,596 shares. Foothills Asset Management Limited holds 43,562 shares. Sandy Spring Financial Bank holds 142,327 shares or 0.96% of its portfolio. Rampart Inv Management Com Ltd Llc has invested 0.33% in Abbott Laboratories (NYSE:ABT). City Fl holds 5,335 shares. Northside Cap Mgmt Ltd holds 0.3% or 9,009 shares. Hanseatic Services Inc owns 10,422 shares for 0.89% of their portfolio. Bnp Paribas Asset has invested 0.45% in Abbott Laboratories (NYSE:ABT). Aviance Partners Llc reported 0.23% of its portfolio in Abbott Laboratories (NYSE:ABT). The Texas-based King Luther Capital Mgmt has invested 1.34% in Abbott Laboratories (NYSE:ABT). Somerset Tru owns 36,138 shares or 1.57% of their US portfolio. New Mexico Educational Retirement Board has invested 0.53% in Abbott Laboratories (NYSE:ABT). Riverbridge Prtnrs Limited Liability Company reported 0.02% in Abbott Laboratories (NYSE:ABT). Moreover, Td Asset Mngmt has 0.26% invested in Abbott Laboratories (NYSE:ABT). Institute For Wealth Mngmt Ltd reported 5,379 shares.

Winslow Capital Management Llc, which manages about $33.78 billion and $18.68B US Long portfolio, upped its stake in Godaddy Inc Cl A by 129,681 shares to 4.04 million shares, valued at $283.55M in 2019Q2, according to the filing. It also increased its holding in Illumina Inc (NASDAQ:ILMN) by 104,953 shares in the quarter, for a total of 1.03 million shares, and has risen its stake in Fortive Corporation.

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: Finance.Yahoo.com which released: “Abbott CEO Miles White Steps Down – Yahoo Finance” on November 13, 2019, also Seekingalpha.com with their article: “Abbott researchers find new strain of HIV – Seeking Alpha” published on November 06, 2019, Finance.Yahoo.com published: “Here’s Why We Think Abbott Laboratories (NYSE:ABT) Is Well Worth Watching – Yahoo Finance” on October 22, 2019. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: Finance.Yahoo.com and their article: “Is Abbott Laboratories (NYSE:ABT) Investing Your Capital Efficiently? – Yahoo Finance” published on July 02, 2019 as well as Prnewswire.com‘s news article titled: “Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 – PRNewswire” with publication date: November 13, 2019.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.